{
    "code": "01050207",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01050207",
    "time": "2024-04-11 19:31:45",
    "許可證字號": "衛署藥製字第050207號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "118\/06\/23",
    "發證\/登錄日期": "98\/06\/23",
    "許可證\/登錄種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHY00105020702",
    "中文品名": "希比洛靜脈乾粉注射劑1公克",
    "英文品名": "Cepiro Powder for I.V. Injection 1gm",
    "適應症": "對Cefpirome Sulphate具感受性細菌引起之感染症。",
    "劑型": "240乾粉注射劑",
    "包裝": "100支以下盒裝 1公克玻璃小瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "CEFPIROME (SULFATE)",
    "限制項目": "01國　產 1R不得製造",
    "申請商名稱": "台灣東洋藥品工業股份有限公司",
    "申請商地址": "台北市南港區園區街3之1號3樓",
    "主製造廠": [
        {
            "製造廠名稱": "中國化學製藥股份有限公司台南三廠",
            "製造廠廠址": "台南市官田區二鎮里工業西路46號之8",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "30042000319 人用醫藥製劑，含頭孢子菌類抗生素者Medicaments, containing cephalosporins, for human use",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0812393110",
            "成分名稱": "CEFPIROME (SULFATE)",
            "含量描述": "(eq. to Cefpirome)(Potency)",
            "含量": "1.0000000000",
            "單位": "GM"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "裸瓶-104-09-09(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01050207&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Cepiro 仿單(藥商變更+2g去除) (D)-107-03-02(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01050207&Seq=008&Type=9"
        },
        {
            "title": "Cepiro 仿單(反) (藥商變更+2g去除) (D)-106-12-15(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01050207&Seq=007&Type=9"
        },
        {
            "title": "Cepiro 仿單(正) (藥商變更+2g去除) (D)-106-12-15(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01050207&Seq=006&Type=9"
        },
        {
            "title": "Cepiro仿單-106-03-20(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01050207&Seq=005&Type=9"
        },
        {
            "title": "Cepiro仿單-106-03-20(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01050207&Seq=004&Type=9"
        },
        {
            "title": "Cepiro 1g 瓶標 (藥商變更+警與 84X40MM)-107-03-02(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01050207&Seq=009&Type=8"
        },
        {
            "title": "Cepiro 1g 外盒 (藥商變更) (C)-107-03-02(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01050207&Seq=008&Type=8"
        },
        {
            "title": "Cepiro 1g 瓶標 (藥商變更) (C)-106-12-15(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01050207&Seq=007&Type=8"
        },
        {
            "title": "Cepiro 1g 外盒 (藥商變更) (C)-106-12-15(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01050207&Seq=006&Type=8"
        },
        {
            "title": "Cepiro外觀,瓶標及外盒-106-03-20(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01050207&Seq=005&Type=8"
        }
    ]
}